Laurus Labs

Market Cap: Large Cap
Industry: Pharmaceuticals & Drugs
ISIN: INE947Q01028
NSEID: LAURUSLABS
BSEID: 540222

INR

604.35

40.95 (7.27%)

BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 21.01 lacs

{
  "main_header": {
    "sid": 1002699,
    "name": "Laurus Labs",
    "stock_name": "Laurus Labs",
    "full_name": "Laurus Labs Ltd",
    "name_url": "stocks-analysis/laurus-labs",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "604.35",
    "chg": 40.95,
    "chgp": "7.27%",
    "dir": 1,
    "prev_price": "563.40",
    "mcapval": "32,589.72 Cr",
    "mcap": "Large Cap",
    "scripcode": 540222,
    "symbol": "LAURUSLABS",
    "ind_name": "Pharmaceuticals & Drugs",
    "ind_code": 4,
    "isin": "INE947Q01028",
    "curr_date": "Apr 11, 12:53 PM",
    "curr_time": "16:20 PM",
    "bse_nse_vol": "21.01 lacs",
    "exc_status": "Active",
    "traded_date": "Apr 11, 2025",
    "traded_date_str": "2025 04 11",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://sandbox-www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/laurus-labs-1002699-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Laurus Labs Sees Significant Open Interest Surge Amid Active Market Participation",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/laurus-labs-sees-10-77-surge-in-open-interest-amid-increased-trading-activity-1699307",
        "imagepath": "",
        "date": "2025-04-03 14:00:25",
        "description": "Laurus Labs Ltd, a prominent player in the Pharmaceuticals & Drugs industry, has experienced a significant increase in open interest (OI) today. The latest OI stands at 17,412 contracts, reflecting a rise of 1,693 contracts or 10.77% from the previous OI of 15,719. This uptick in OI comes alongside a trading volume of 15,786 contracts, indicating active market participation.\n\nIn terms of price performance, Laurus Labs is currently trading close to its 52-week high, just 4.23% away from Rs 646.2. The stock has shown resilience, gaining 3.52% over the past two days, although it underperformed its sector by 0.42% today. The intraday high reached Rs 638.9, marking a 4.9% increase during the session.\n\nLaurus Labs is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, suggesting a strong upward trend in its price trajectory. However, delivery volume has seen a decline of 41.59% compared..."
      },
      {
        "title": "Laurus Labs Sees Surge in Open Interest Amid Active Market Engagement",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/laurus-labs-sees-10-03-surge-in-open-interest-to-17296-contracts-1698176",
        "imagepath": "",
        "date": "2025-04-03 13:00:18",
        "description": "Laurus Labs Ltd, a prominent player in the Pharmaceuticals & Drugs sector, has experienced a significant increase in open interest today. The latest open interest stands at 17,296 contracts, reflecting a rise of 1,577 contracts or 10.03% from the previous open interest of 15,719. This uptick in open interest coincides with a trading volume of 13,879 contracts, indicating active engagement in the stock.\n\nIn terms of price performance, Laurus Labs is currently trading close to its 52-week high, just 4.33% away from Rs 646.2. The stock has shown resilience, gaining 3.42% over the last two days, although it underperformed its sector by 0.57% today. The intraday high reached Rs 638.9, marking a 4.9% increase during the session. Notably, Laurus Labs is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, suggesting a strong upward trend in its price trajectory.\n\nDespite the positive pric..."
      },
      {
        "title": "Laurus Labs Sees Surge in Open Interest Amid Active Market Participation",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/laurus-labs-sees-10-03-surge-in-open-interest-reaching-17296-contracts-1696928",
        "imagepath": "",
        "date": "2025-04-03 12:00:22",
        "description": "Laurus Labs Ltd, a prominent player in the Pharmaceuticals & Drugs sector, has experienced a significant increase in open interest (OI) today. The latest OI stands at 17,296 contracts, reflecting a rise of 1,577 contracts or 10.03% from the previous OI of 15,719. This uptick in OI comes alongside a trading volume of 13,879 contracts, indicating active market participation.\n\nIn terms of price performance, Laurus Labs has shown resilience, gaining 2.71% over the last two days, despite underperforming its sector by 1.49% today. The stock reached an intraday high of Rs 638.9, marking a 4.9% increase. Notably, Laurus Labs is currently trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, suggesting a positive trend in its price trajectory.\n\nHowever, it is worth mentioning that the delivery volume has seen a decline of 41.59% compared to the 5-day average, with a total delivery volume of ..."
      },
      {
        "title": "Laurus Labs Outperforms Market Amidst Sector Gains and Volatile Conditions",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/laurus-labs-stock-rises-3-97-approaches-52-week-high-amid-positive-trend-1693585",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/4/LaurusLabs_priceRelatedfactors_883383.png",
        "date": "2025-04-03 09:35:26",
        "description": "Laurus Labs has demonstrated strong performance in the Pharmaceuticals & Drugs sector, gaining 3.97% on April 3, 2025, and trading close to its 52-week high. The stock has increased 5.42% over two days and is performing well against its moving averages, outperforming the broader market and the Sensex over the past year."
      },
      {
        "title": "Laurus Labs Shows Mixed Technical Trends Amid Strong Market Performance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/laurus-labs-technical-trend-shifts-from-mildly-bullish-to-bullish-amid-strong-stock-performance-1692525",
        "imagepath": "",
        "date": "2025-04-03 08:05:47",
        "description": "Laurus Labs, a prominent player in the Pharmaceuticals & Drugs sector, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 606.35, showing a notable increase from the previous close of 598.00. Over the past year, Laurus Labs has demonstrated significant performance, with a return of 46.06%, substantially outperforming the Sensex, which recorded a return of 3.67% in the same period.\n\nThe technical summary indicates a mixed outlook, with various indicators reflecting different trends. The Moving Averages signal a bullish stance on a daily basis, while the MACD presents a mildly bearish trend on a weekly basis but shifts to bullish on a monthly scale. The Bollinger Bands also suggest a mildly bullish trend across both weekly and monthly evaluations. \n\nIn terms of stock performance, Laurus Labs has shown resilience, particularly over the last fi..."
      },
      {
        "title": "Laurus Labs Shows Mixed Signals Amid Recent Financial Turnaround and Growth Concerns",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/laurus-labs-stock-downgraded-to-hold-amid-technical-grade-shift-and-price-decline-1671796",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/4/LaurusLabs_mojoScore_862631.png",
        "date": "2025-04-02 08:27:25",
        "description": "Laurus Labs, a key player in the Pharmaceuticals & Drugs sector, has experienced a recent evaluation adjustment amid mixed technical indicators. The company reported a positive financial turnaround, highlighted by strong operational efficiency and a high return on capital employed, despite facing long-term growth challenges."
      },
      {
        "title": "Laurus Labs Shows Mixed Technical Trends Amid Strong Long-Term Growth Performance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/laurus-labs-technical-trend-shifts-from-bullish-to-mildly-bullish-amid-price-decline-1670985",
        "imagepath": "",
        "date": "2025-04-02 08:08:58",
        "description": "Laurus Labs, a prominent player in the Pharmaceuticals & Drugs sector, has recently undergone an evaluation revision reflecting its current market dynamics. The company's stock is currently priced at 598.00, with a previous close of 611.00. Over the past year, Laurus Labs has demonstrated a notable return of 47.53%, significantly outperforming the Sensex, which recorded a return of 2.72% during the same period. \n\nIn terms of technical indicators, the weekly MACD shows a mildly bearish trend, while the monthly perspective remains bullish. The Bollinger Bands indicate a mildly bullish stance on both weekly and monthly charts, suggesting some positive momentum. Daily moving averages are bullish, indicating a favorable short-term outlook. \n\nLaurus Labs has also shown resilience in its performance metrics, with a 52-week high of 646.25 and a low of 386.85. The stock's performance over various time frames reveals..."
      },
      {
        "title": "Laurus Labs Outperforms Sector Amid Broader Market Challenges and Positive Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/laurus-labs-achieves-3-29-gain-outperforming-sector-and-sensex-performance-1457479",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/LaurusLabs_priceRelatedfactors_719082.png",
        "date": "2025-03-19 14:50:24",
        "description": "Laurus Labs has demonstrated strong performance, gaining 3.29% on March 19, 2025, and outperforming its sector. The stock has risen consistently over three days, accumulating a total return of 6.24%. It is trading above key moving averages, reflecting a robust upward trend amid broader market fluctuations."
      },
      {
        "title": "Laurus Labs Reports Strong Financial Turnaround, Signaling Resilience in Pharmaceuticals Sector",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/laurus-labs-receives-buy-rating-after-positive-financial-turnaround-and-strong-performance-1423650",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/LaurusLabs_mojoScore_682579.png",
        "date": "2025-03-18 08:16:49",
        "description": "Laurus Labs has recently experienced a change in its evaluation, reflecting a positive financial turnaround after seven challenging quarters. The company reported strong operational metrics, including a return on capital employed of 18.89% and a notable operating profit to net sales ratio, indicating effective cost management and resilience in the pharmaceutical sector."
      }
    ],
    "total": 133,
    "sid": "1002699",
    "stock_news_url": "https://sandbox-www.marketsmojo.com/news/laurus-labs-1002699"
  },
  "announcements": [
    {
      "caption": "Intimation Of Grant Of Stock Options To The Eligible Employees",
      "datetime": "28-Mar-2025",
      "details": "Please see annexed enclosure.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Acquisition",
      "datetime": "28-Mar-2025",
      "details": "Please see annexed enclosure.",
      "source": "BSE"
    },
    {
      "caption": "Intimation Of Re-Appointment Of Executive Directors Of The Company Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.",
      "datetime": "28-Mar-2025",
      "details": "Please see annexed enclosure.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Laurus Labs Ltd has declared <strong>20%</strong> dividend, ex-date: 06 Nov 24",
          "dt": "2024-11-06",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Laurus Labs Ltd has announced <strong>2:10</strong> stock split, ex-date: 29 Sep 20",
          "dt": "2020-09-29",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Laurus Labs Sees Significant Open Interest Surge Amid Active Market Participation

2025-04-03 14:00:25

Laurus Labs Ltd, a prominent player in the Pharmaceuticals & Drugs industry, has experienced a significant increase in open interest (OI) today. The latest OI stands at 17,412 contracts, reflecting a rise of 1,693 contracts or 10.77% from the previous OI of 15,719. This uptick in OI comes alongside a trading volume of 15,786 contracts, indicating active market participation. In terms of price performance, Laurus Labs is currently trading close to its 52-week high, just 4.23% away from Rs 646.2. The stock has shown resilience, gaining 3.52% over the past two days, although it underperformed its sector by 0.42% today. The intraday high reached Rs 638.9, marking a 4.9% increase during the session. Laurus Labs is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, suggesting a strong upward trend in its price trajectory. However, delivery volume has seen a decline of 41.59% compared...

Laurus Labs Sees Surge in Open Interest Amid Active Market Engagement

2025-04-03 13:00:18

Laurus Labs Ltd, a prominent player in the Pharmaceuticals & Drugs sector, has experienced a significant increase in open interest today. The latest open interest stands at 17,296 contracts, reflecting a rise of 1,577 contracts or 10.03% from the previous open interest of 15,719. This uptick in open interest coincides with a trading volume of 13,879 contracts, indicating active engagement in the stock. In terms of price performance, Laurus Labs is currently trading close to its 52-week high, just 4.33% away from Rs 646.2. The stock has shown resilience, gaining 3.42% over the last two days, although it underperformed its sector by 0.57% today. The intraday high reached Rs 638.9, marking a 4.9% increase during the session. Notably, Laurus Labs is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, suggesting a strong upward trend in its price trajectory. Despite the positive pric...

Laurus Labs Sees Surge in Open Interest Amid Active Market Participation

2025-04-03 12:00:22

Laurus Labs Ltd, a prominent player in the Pharmaceuticals & Drugs sector, has experienced a significant increase in open interest (OI) today. The latest OI stands at 17,296 contracts, reflecting a rise of 1,577 contracts or 10.03% from the previous OI of 15,719. This uptick in OI comes alongside a trading volume of 13,879 contracts, indicating active market participation. In terms of price performance, Laurus Labs has shown resilience, gaining 2.71% over the last two days, despite underperforming its sector by 1.49% today. The stock reached an intraday high of Rs 638.9, marking a 4.9% increase. Notably, Laurus Labs is currently trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, suggesting a positive trend in its price trajectory. However, it is worth mentioning that the delivery volume has seen a decline of 41.59% compared to the 5-day average, with a total delivery volume of ...

Laurus Labs Outperforms Market Amidst Sector Gains and Volatile Conditions

2025-04-03 09:35:26

Laurus Labs has demonstrated strong performance in the Pharmaceuticals & Drugs sector, gaining 3.97% on April 3, 2025, and trading close to its 52-week high. The stock has increased 5.42% over two days and is performing well against its moving averages, outperforming the broader market and the Sensex over the past year.

Laurus Labs Shows Mixed Technical Trends Amid Strong Market Performance

2025-04-03 08:05:47

Laurus Labs, a prominent player in the Pharmaceuticals & Drugs sector, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 606.35, showing a notable increase from the previous close of 598.00. Over the past year, Laurus Labs has demonstrated significant performance, with a return of 46.06%, substantially outperforming the Sensex, which recorded a return of 3.67% in the same period. The technical summary indicates a mixed outlook, with various indicators reflecting different trends. The Moving Averages signal a bullish stance on a daily basis, while the MACD presents a mildly bearish trend on a weekly basis but shifts to bullish on a monthly scale. The Bollinger Bands also suggest a mildly bullish trend across both weekly and monthly evaluations. In terms of stock performance, Laurus Labs has shown resilience, particularly over the last fi...

Laurus Labs Shows Mixed Signals Amid Recent Financial Turnaround and Growth Concerns

2025-04-02 08:27:25

Laurus Labs, a key player in the Pharmaceuticals & Drugs sector, has experienced a recent evaluation adjustment amid mixed technical indicators. The company reported a positive financial turnaround, highlighted by strong operational efficiency and a high return on capital employed, despite facing long-term growth challenges.

Laurus Labs Shows Mixed Technical Trends Amid Strong Long-Term Growth Performance

2025-04-02 08:08:58

Laurus Labs, a prominent player in the Pharmaceuticals & Drugs sector, has recently undergone an evaluation revision reflecting its current market dynamics. The company's stock is currently priced at 598.00, with a previous close of 611.00. Over the past year, Laurus Labs has demonstrated a notable return of 47.53%, significantly outperforming the Sensex, which recorded a return of 2.72% during the same period. In terms of technical indicators, the weekly MACD shows a mildly bearish trend, while the monthly perspective remains bullish. The Bollinger Bands indicate a mildly bullish stance on both weekly and monthly charts, suggesting some positive momentum. Daily moving averages are bullish, indicating a favorable short-term outlook. Laurus Labs has also shown resilience in its performance metrics, with a 52-week high of 646.25 and a low of 386.85. The stock's performance over various time frames reveals...

Laurus Labs Outperforms Sector Amid Broader Market Challenges and Positive Momentum

2025-03-19 14:50:24

Laurus Labs has demonstrated strong performance, gaining 3.29% on March 19, 2025, and outperforming its sector. The stock has risen consistently over three days, accumulating a total return of 6.24%. It is trading above key moving averages, reflecting a robust upward trend amid broader market fluctuations.

Laurus Labs Reports Strong Financial Turnaround, Signaling Resilience in Pharmaceuticals Sector

2025-03-18 08:16:49

Laurus Labs has recently experienced a change in its evaluation, reflecting a positive financial turnaround after seven challenging quarters. The company reported strong operational metrics, including a return on capital employed of 18.89% and a notable operating profit to net sales ratio, indicating effective cost management and resilience in the pharmaceutical sector.